In Other Journals

Ann Gregory
Med J Aust 2006; 184 (7): . || doi: 10.5694/j.1326-5377.2006.tb00275.x
Published online: 3 April 2006

A small pilot trial conducted in Taiwan has suggested that stem cell therapy may have a place in the future treatment of ischaemic stroke.1 Shyu and colleagues allocated at random 10 patients who presented within 7 days of acute cerebral infarction localised within the middle cerebral artery territory to receive either 5 days of subcutaneous injections of granulocyte colony-stimulating factor (G-CSF) or usual care. Six months later, the seven patients who received G-CSF showed a greater improvement in neurological functioning. Four patients who started treatment within 1 day after onset of cerebral ischaemia showed the greatest improvement.

  • Ann Gregory



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.